Tech Company Financing Transactions

Ajax Therapeutics Funding Round

EcoR1 Capital Management, Boxer Capital and Memorial Sloan Kettering Cancer Center participated in a $40 million venture round for Ajax Therapeutics. The round was announced by the company on 6/2/2021.

Transaction Overview

Company Name
Announced On
6/2/2021
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors

EcoR1 Capital Management (Lead Investor) (Scott Platshon)

Boxer Capital

Memorial Sloan Kettering Cancer Center

NYU Langone Health

OneVentures

Schrodinger

Proceeds Purpose
Proceeds from the financing will support the advancement of Ajax' lead drug development programs targeting hematologic malignancies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
275 Madison Ave. 39th floor
New York, NY 10016
USA
Email Address
Overview
Advances in molecular genetics and biology have led to the development of new classes of targeted therapies for the treatment of hematologic malignancies. However, many of these therapies, while selective for a particular drug target, often interact with other related proteins which can limit their efficacy and lead to unwanted side effects.
Profile
Ajax Therapeutics LinkedIn Company Profile
Social Media
Ajax Therapeutics Company Twitter Account
Company News
Ajax Therapeutics News
Facebook
Ajax Therapeutics on Facebook
YouTube
Ajax Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Martin Vogelbaum
  Martin Vogelbaum LinkedIn Profile  Martin Vogelbaum Twitter Account  Martin Vogelbaum News  Martin Vogelbaum on Facebook
VP - R & D
Craig Masse
  Craig Masse LinkedIn Profile  Craig Masse Twitter Account  Craig Masse News  Craig Masse on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/2/2021: Electric Era venture capital transaction
Next: 6/2/2021: Notal Vision venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary